Search for: "GENENTECH, INC." Results 321 - 340 of 469
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2010, 5:46 am by Lawrence B. Ebert
The rub:Although the PTO emphasizes that it was required to give all “claims their broadest reasonable construction” particularly with respect to claim 4’s use of the open- ended term “comprising,” see Genentech, Inc. v. [read post]
14 Apr 2010, 10:57 am
Although the PTO emphasizes that it was required to give all "claims their broadest reasonable construction" particularly with respect to claim 4's use of the open-ended term "comprising," see Genentech, Inc. v. [read post]
5 Apr 2010, 9:29 am
Genentech set the stage for declaratory judgment actions at the sound of a snort from a patent holder. [read post]
28 Mar 2010, 8:33 pm by Patent Docs
Glaxosmithkline LLC et al. 3:10-cv-00608; filed March 24, 2010 in the Southern District of California • Plaintiffs: Biogen Idec, Inc.; Genentech, Inc. [read post]
14 Mar 2010, 8:18 am by Lawrence B. Ebert
Genentech," which includes the text:This case arises out of a 1976 patent agreement (the agreement) that governs the right of respondent City of Hope National Medical Center (City of Hope) to receive royalties from appellant Genentech, Inc. [read post]
4 Mar 2010, 3:17 pm by admin
– Environmental Protection Agency, Federal Register, February 25, 2010 In accordance with the requirements of section 122(h)(1) of the Comprehensive Environmental Response, Compensation, and Liability Act, as amended (CERCLA), 42 U.S.C. 9622(h)(1), notice is hereby given of a Settlement Agreement under sections 104, 106(a), 107, and 122 of CERCLA, 42 U.S.C. 9604, 9606(a), 9607, and 9622, between the United States Environmental Protection Agency (EPA) and Colorado Bumper Exchange, Inc.… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
21 Dec 2009, 5:24 am
(Business IP and Intangible Asset Report and Blog)   Global - Patents New exchange, Intellectual Property Exchange International, can be a game-changer, but will need good patents to thrive (IAM) (Technology Transfer Tactics)   Australia Bittersweet decision for Mars but Cadbury settles purple dispute: Mars Australia Pty Ltd v Sweet Rewards Pty Ltd (Managing IP) (ipwars)   Belgium Belgian Supreme Court prohibits fishing expeditions: Ineos Manufacturing Belgium NV and Ineos Services… [read post]
8 Dec 2009, 12:33 pm by Matt Osenga
Genentech, Inc., wittingly or not, lowered the bar for declaratory judgment actions. [read post]
5 Dec 2009, 1:01 am
Genentech, Inc., 549 U.S. 118, 127 (2007). [read post]